V-bella Suppository
NDC Package 52747-155-03
Package Information
V-bella (boric acid) suppositories is before using this product, read all consumer information provided on carton and insert,Adults and children 12 years of age and over:place vaginal capsule suppository in applicator and gently insert into the vagina.for acute infection, use one (1) capsule suppository a day for three (3) daysfor chronic infection, use an additional package of three (3) vaginal capsule suppositoriesthrow applicator away after each useChildren under 12 years of age: ask a doctor. This formulation utilizes a suppository delivery system. Marketed by U.s. Pharmaceutical Corporation, this product is identified by NDC 52747-155.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 52747 - U.s. Pharmaceutical Corporation
- 52747-155 - V-bella
- 52747-155-03 - 3 PACKET in 1 CARTON / 1 SUPPOSITORY in 1 PACKET
- 52747-155 - V-bella
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 52747-155-03 identifies a specific commercial package of 3 packet in 1 carton / 1 suppository in 1 packet of V-bella, a human over the counter drug labeled by U.s. Pharmaceutical Corporation. This suppository is formulated for vaginal use and contains boric acid as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by U.s. Pharmaceutical Corporation on August 01, 2020. The current certification is valid through December 31, 2026.
How is this U.s. Pharmaceutical Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 52747015503. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.